NDAQ (NASDAQ: NDAQ) insider files to sell 6,000 shares, lists prior 13,000 sale

Rhea-AI Filing Summary

Bradley J. Peterson filed a notice to potentially sell up to 6,000 shares of NDAQ common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on August 7, 2026, with a reported aggregate market value of $573,300.60. The shares relate to Performance Shares acquired from the issuer on February 11, 2026. In the preceding three months, Peterson reported selling 13,000 shares of common stock on July 24, 2026 for $1,203,910.50.

Key Figures

Proposed shares to be sold: 6,000 shares Aggregate market value of proposed sale: $573,300.60 Shares sold in prior 3 months: 13,000 shares +3 more

6 metrics

Proposed shares to be sold 6,000 shares Common stock proposed for sale on August 7, 2026

Aggregate market value of proposed sale $573,300.60 Value reported for 6,000 common shares

Shares sold in prior 3 months 13,000 shares Common stock sale on July 24, 2026

Proceeds from prior sale $1,203,910.50 Total reported for 13,000 shares sold July 24, 2026

Acquisition date of Performance Shares February 11, 2026 Issuer-related Performance Shares underlying the common stock

Planned sale date August 7, 2026 Date listed for proposed sale of 6,000 shares

Key Terms

Form 144, Performance Shares, aggregate market value

3 terms

Form 144 regulatory

"144: Securities Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Shares financial

"Common | 02/11/2026 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

aggregate market value financial

"Common | ... | 6000 | 573300.60 | 558977372"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:07 PM Accepted by SEC EDGAR 08/07/2026 - 04:06 PM Learn about SEC filing dates

FAQ

What does the Form 144 filing by Bradley J. Peterson mean for NDAQ investors?

Bradley J. Peterson filed a Form 144 indicating an intent to sell up to 6,000 NDAQ common shares on August 7, 2026. This is a regulatory notice of a potential sale, not a confirmation that all shares will be sold.

How many NDAQ shares does Bradley J. Peterson plan to sell under this Form 144?

The filing indicates a proposed sale of up to 6,000 shares of NDAQ common stock. These shares have a reported aggregate market value of $573,300.60 and are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.

What type of NDAQ securities are covered in Bradley J. Peterson’s Form 144?

The Form 144 covers common stock of NDAQ, related to Performance Shares acquired from the issuer on February 11, 2026. The filing specifies these performance-based shares as the source of the stock proposed for sale.

Which broker is handling the potential NDAQ share sale for Bradley J. Peterson?

The planned sale of up to 6,000 NDAQ shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, according to the Form 144 disclosure.

Has Bradley J. Peterson sold NDAQ shares in the past three months?

Yes. The Form 144 reports that on July 24, 2026, Bradley J. Peterson sold 13,000 NDAQ common shares for total proceeds of $1,203,910.50. This prior sale is disclosed as required for the preceding three‑month period.

What is the reported value of NDAQ shares in Bradley J. Peterson’s planned Form 144 sale?

The planned sale of up to 6,000 NDAQ common shares has a reported aggregate market value of $573,300.60. This figure reflects the valuation used in the Form 144 notice for the proposed transaction on August 7, 2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6000	573300.60	558977372	08/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2026	Performance Shares	Issuer			6000	02/11/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRADLEY J PETERSON 151 W. 42nd Street, New York NY 10036	Common	07/24/2026	13000	1203910.50

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)